US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 89.400
  • -2.220-2.42%
Close Dec 27 16:00 ET
  • 89.400
  • 0.0000.00%
Post 17:16 ET
5.68BMarket Cap-42.78P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
126.61%128.18M
139.98%138.16M
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
13.30%204.04M
-63.76%38.78M
Operating revenue
126.61%128.18M
139.98%138.16M
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
13.30%204.04M
-63.76%38.78M
Cost of revenue
-30.55%1.93M
226.86%7.59M
0.50%3.19M
-52.06%8.54M
-94.64%260K
-7.27%2.78M
-52.46%2.32M
-37.49%3.18M
-0.67%17.81M
-35.78%4.85M
Gross profit
134.74%126.25M
136.33%130.56M
54.59%92.93M
29.33%240.84M
111.29%71.7M
-14.60%53.78M
74.50%55.25M
4.27%60.11M
14.85%186.22M
-65.89%33.93M
Operating expense
-3.19%175.23M
-4.61%173.61M
-6.16%171.75M
1.13%722.86M
-2.75%176.85M
-2.48%180.99M
-2.76%181.99M
14.25%183.02M
-10.24%714.79M
-55.76%181.86M
Selling and administrative expenses
27.12%89.93M
24.20%89.34M
17.77%83.56M
24.34%295.14M
23.89%79.32M
22.80%70.74M
22.57%71.93M
24.35%70.95M
21.55%237.37M
18.12%64.02M
-Selling and marketing expense
104.58%26.74M
99.77%22.71M
68.46%16.93M
----
----
69.34%13.07M
18.10%11.37M
--10.05M
----
----
-General and administrative expense
9.56%63.19M
10.02%66.63M
9.40%66.63M
----
----
15.60%57.67M
23.44%60.56M
--60.9M
----
----
Research and development costs
-22.63%85.3M
-23.43%84.27M
-21.31%88.19M
-10.41%427.72M
-17.23%97.54M
-13.85%110.25M
-14.33%110.06M
8.67%112.07M
-20.57%477.42M
-66.98%117.84M
Operating profit
61.50%-48.97M
66.04%-43.05M
35.87%-78.82M
8.81%-482.02M
28.91%-105.15M
-3.75%-127.21M
18.49%-126.75M
-19.87%-122.91M
16.65%-528.57M
52.53%-147.93M
Net non-operating interest income expense
-100.00%-7.62M
-71.77%-6.86M
-1.31%-5.9M
-12.08%-18.79M
44.06%-5.17M
54.65%-3.81M
-1,035.83%-4M
-1,416.52%-5.82M
-802.72%-16.77M
-2,095.68%-9.24M
Non-operating interest income
19.52%11.15M
28.22%9.94M
55.56%9.18M
----
----
216.24%9.33M
1,689.61%7.75M
--5.9M
----
----
Non-operating interest expense
42.85%18.77M
43.04%16.8M
28.62%15.07M
----
----
15.79%13.14M
195,650.00%11.75M
--11.72M
----
----
Total other finance cost
----
----
----
12.08%18.79M
----
----
----
----
802.72%16.77M
----
Other net income (expense)
123.49%587K
100.91%17K
56,240.00%174.03M
25.09%-5.2M
-20.09%-532K
-96.93%-2.5M
-22.93%-1.86M
91.66%-310K
25.25%-6.94M
90.98%-443K
Earnings from equity interest
--0
--0
--0
52.44%-4.26M
102.40%45K
-6.37%-1.77M
42.47%-1.23M
60.31%-1.3M
-14.70%-8.95M
58.69%-1.87M
Special income (charges)
--0
--18K
--173.66M
----
----
--0
--0
--0
----
----
-Less:Other special charges
----
---18K
---173.66M
----
----
----
----
----
----
----
Other non- operating income (expenses)
180.63%587K
99.84%-1K
-61.87%376K
-147.21%-946K
-140.38%-577K
-283.84%-728K
-199.05%-626K
317.66%986K
234.59%2M
476.05%1.43M
Income before tax
58.06%-56M
62.37%-49.89M
169.22%89.32M
8.38%-506.02M
29.66%-110.86M
-0.94%-133.52M
15.31%-132.6M
-21.95%-129.04M
13.85%-552.28M
50.13%-157.61M
Income tax
38.58%273K
-46.32%102K
-65.38%180K
-81.51%968K
-94.11%61K
-77.77%197K
-93.93%190K
182.61%520K
74.48%5.24M
-60.65%1.04M
Net income
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
Net income continuous Operations
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
Minority interest income
Net income attributable to the parent company
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
Basic earnings per share
59.55%-0.89
63.47%-0.8
167.44%1.45
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
15.08%-9.35
50.93%-2.65
Diluted earnings per share
59.55%-0.89
63.47%-0.8
165.12%1.4
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
15.08%-9.35
50.93%-2.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 126.61%128.18M139.98%138.16M51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M13.30%204.04M-63.76%38.78M
Operating revenue 126.61%128.18M139.98%138.16M51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M13.30%204.04M-63.76%38.78M
Cost of revenue -30.55%1.93M226.86%7.59M0.50%3.19M-52.06%8.54M-94.64%260K-7.27%2.78M-52.46%2.32M-37.49%3.18M-0.67%17.81M-35.78%4.85M
Gross profit 134.74%126.25M136.33%130.56M54.59%92.93M29.33%240.84M111.29%71.7M-14.60%53.78M74.50%55.25M4.27%60.11M14.85%186.22M-65.89%33.93M
Operating expense -3.19%175.23M-4.61%173.61M-6.16%171.75M1.13%722.86M-2.75%176.85M-2.48%180.99M-2.76%181.99M14.25%183.02M-10.24%714.79M-55.76%181.86M
Selling and administrative expenses 27.12%89.93M24.20%89.34M17.77%83.56M24.34%295.14M23.89%79.32M22.80%70.74M22.57%71.93M24.35%70.95M21.55%237.37M18.12%64.02M
-Selling and marketing expense 104.58%26.74M99.77%22.71M68.46%16.93M--------69.34%13.07M18.10%11.37M--10.05M--------
-General and administrative expense 9.56%63.19M10.02%66.63M9.40%66.63M--------15.60%57.67M23.44%60.56M--60.9M--------
Research and development costs -22.63%85.3M-23.43%84.27M-21.31%88.19M-10.41%427.72M-17.23%97.54M-13.85%110.25M-14.33%110.06M8.67%112.07M-20.57%477.42M-66.98%117.84M
Operating profit 61.50%-48.97M66.04%-43.05M35.87%-78.82M8.81%-482.02M28.91%-105.15M-3.75%-127.21M18.49%-126.75M-19.87%-122.91M16.65%-528.57M52.53%-147.93M
Net non-operating interest income expense -100.00%-7.62M-71.77%-6.86M-1.31%-5.9M-12.08%-18.79M44.06%-5.17M54.65%-3.81M-1,035.83%-4M-1,416.52%-5.82M-802.72%-16.77M-2,095.68%-9.24M
Non-operating interest income 19.52%11.15M28.22%9.94M55.56%9.18M--------216.24%9.33M1,689.61%7.75M--5.9M--------
Non-operating interest expense 42.85%18.77M43.04%16.8M28.62%15.07M--------15.79%13.14M195,650.00%11.75M--11.72M--------
Total other finance cost ------------12.08%18.79M----------------802.72%16.77M----
Other net income (expense) 123.49%587K100.91%17K56,240.00%174.03M25.09%-5.2M-20.09%-532K-96.93%-2.5M-22.93%-1.86M91.66%-310K25.25%-6.94M90.98%-443K
Earnings from equity interest --0--0--052.44%-4.26M102.40%45K-6.37%-1.77M42.47%-1.23M60.31%-1.3M-14.70%-8.95M58.69%-1.87M
Special income (charges) --0--18K--173.66M----------0--0--0--------
-Less:Other special charges -------18K---173.66M----------------------------
Other non- operating income (expenses) 180.63%587K99.84%-1K-61.87%376K-147.21%-946K-140.38%-577K-283.84%-728K-199.05%-626K317.66%986K234.59%2M476.05%1.43M
Income before tax 58.06%-56M62.37%-49.89M169.22%89.32M8.38%-506.02M29.66%-110.86M-0.94%-133.52M15.31%-132.6M-21.95%-129.04M13.85%-552.28M50.13%-157.61M
Income tax 38.58%273K-46.32%102K-65.38%180K-81.51%968K-94.11%61K-77.77%197K-93.93%190K182.61%520K74.48%5.24M-60.65%1.04M
Net income 57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M
Net income continuous Operations 57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M
Minority interest income
Net income attributable to the parent company 57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M
Basic earnings per share 59.55%-0.8963.47%-0.8167.44%1.4510.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.1515.08%-9.3550.93%-2.65
Diluted earnings per share 59.55%-0.8963.47%-0.8165.12%1.410.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.1515.08%-9.3550.93%-2.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday-0.12%